Rada JR, et al.1818 Rojano Rada J, Terán Pereira P, Grassa LL. Caracterización clínica y epidemiológica de pacientes con psoriasis y prescripción de terapia biológica en Venezuela: estudio transversal. Medwave. 2020;20:e8064.
|
2020 |
374 |
CS |
Venezuela |
Public |
Opportunistic and endemic infections |
Quiroz-Vergara JC, et al.2929 Quiroz-Vergara JC, Morales-Sánchez MA, Castillo-Rojas G, López-Vidal Y, Peralta-Pedrero ML, Jurado-Santa Cruz F, et al. Late diagnosis of psoriasis: Reasons and consequences. Gac Med Mex. 2017;153:305-12.
|
2017 |
100 |
CS |
Mexico |
Public |
Delayed diagnosis |
Andrade DL, et al.2323 Andrade DL, De M, Paim De Oliveira F, Pereira De Souza TF, Lima RA, Bomfim EA, et al. Estudio sobre la infección por el virus de la hepatitis C en pacientes con psoriasis de un centro de referência de Brasil. Acta Gastroenterol Latinoam. 2012;42:285-90.
|
2012 |
140 |
CS |
Brazil |
Public |
Opportunistic and endemic infections |
Araujo KM, et al.2626 Araujo KM, Bressan AL, Azulay-Abulafia L. Zika, chikungunya, and dengue infections as exacerbating factors of psoriasis in patients receiving biological therapy. Int J Dermatol. 2020;59:e209-11.
|
2020 |
56 |
RC |
Brazil |
Public |
Opportunistic and endemic infections |
Figueroa P, et al.1919 Figueroa P, Barbini C, Parigini A, Eimer I, Suar I, De Pablo A, et al. Prevalence and incidence of latent tuberculosis in patients with moderate to severe psoriasis under systemic treatment in the Dermatology Service of the Hospital Universitario Austral. [Internet]. [cited 2023 Apr 13]. Available from: https://www.wcd2019milan-dl.org/abstract-book/documents/abstracts/35-psoriasis/prevalence-and-incidence-of-latent-2177.pdf. https://www.wcd2019milan-dl.org/abstract...
|
2018 |
93 |
CS and RC |
Argentina |
Public |
Opportunistic and endemic infections |
Kurizky PS, et al.2424 Kurizky PS, Gomes CM, Cesetti MV, Martins GA, Regattieri NAT, Marianelli FF, et al. Cross-sectional screening study for Leishmania DNA and antibodies in biologic-treated patients with psoriasis living in an area endemic for leishmaniasis. Br J Dermatol. 2019;181:1337-9.
|
2019 |
311 |
CS |
Brazil |
Public |
Opportunistic and endemic infections |
Lopes N, et al.3030 Lopes N, Dias LLS, Azulay-Abulafia L, Oyafuso LKM, Suarez MV, Fabricio L, et al. Humanistic and economic impact of moderate to severe plaque Psoriasis in Brazil. Adv Ther. 2019;36:2849-2865.
|
2019 |
188 |
CS |
Brazil |
Private |
Access to medication/medical care/Work productivity |
Úsuga F, et al.1414 Usuga FA, Gutiérrez G, Quirós Gomez O, Velásquez Lopera M. Perspectives of colombian patients with psoriasis on access to treatment and its repercussion on the social environment. An experience of Fundapso. J Eur Acad Dermatology Venereol. 2019;33:85.
|
2019 |
312 |
CS |
Colombia |
Public |
Access to medication/medical care |
Lopes N, et al.66 Lopes N, Suzuki C, Machado P. Access to Psoriasis drug treatment among Brazilian patients. Value Health. 2017;20:A568.
|
2017 |
188 |
CS |
Brazil |
Private |
Access to medication/medical care |
Lopes LC, et al.1717 Lopes LC, Silveira MS, de Camargo IA, Barberato-Filho S, Del Fiol F de S, Osoriode-Castro CGS. Biological drugs for the treatment of psoriasis in a public health system. Rev Saude Publica. 2014;48:651-61.
|
2014 |
203 |
CS |
Brazil |
Public |
Access to medication/medical care |
Ferreira CN, et al.3131 Ferreira CN, DiBonaventura MD, Tang B, Rufino CS, Manfrin DF. Economic burden of Psoriatic patients in the brazilian health system. Value Health. 2014;17:A226.
|
2014 |
210 |
CS |
Brazil |
Private |
Work productivity |
Kivelevitch DN, et al.2828 Kivelevitch DN, Tahhan PV, Bourren P, Kogan NN, Gusis SE, Rodríguez EA. Self-medication and adherence to treatment in psoriasis. Int J Dermatol. 2012;51:416-9.
|
2012 |
176 |
CS |
Argentina |
Public |
Adherence to treatment |
Maza RGC77 Contreras Maza RG. Incidencia de tuberculosis en pacientes con psoriasis que reciben terapias anti- TNF- alfa en Latinoamérica: revisión sistemática y metaanálisis. An Fac Med. 2019;80:73-8.
|
2019 |
510.9 patient-years |
MA |
Latin America |
Public |
Opportunistic and endemic infections |
Silveira MSN, et al.3333 Silveira MS, de Camargo IA, Osorio-de-Castro CGS, Barberato-Filho S, Del Fiol F de S, Guyatt G, et al. Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil. BMJ Open. 2014;4:e004179.
|
2014 |
203 |
CS |
Brazil |
Public |
Access to medication/medical care/Adherence to treatment guidelines |
Gonçalves LMT, et al.2121 Tanaka Gonçalves L, Vicente Cesetti M, Shu Kurizky P, Ferraço Marianelli F, Suelen Jacques Sousa De Assis F, Aparecida De Paula N, et al. Identification of Mycobacterium leprae DNA in psoriasis and/or psoriatic arthritis patients under immunobiological therapy [Internet]. [cited 2023 Apr 13]. Available from: https://www.wcd2019milan-dl.org/abstract-book/documents/abstracts/22-infectious-diseases/identification-of-mycobacterium-leprae-dna-5556.pdf. https://www.wcd2019milan-dl.org/abstract...
|
2019 |
311 |
CS |
Brazil |
Public |
Opportunistic and endemic infections |
DiBonaventura M, et al.1515 Dibonaventura M, Souza C da S, Ferreira CN, de Carvalho AVE, Squiassi HB. The association between psoriasis and health-related quality of life, work productivity, and healthcare resource use in Brazil. An Bras Dermatol. 2018;93:197-204.
|
2018 |
12000 |
CS |
Brazil |
Private |
Access to medication/medical care/Work productivity |
Mazzuoccoloa LD, et al.3232 Mazzuoccolo LD, Luna PC, Marciano S, Castro Perez GA, Marchesi C, Nocito MJ, et al. Real-world prescription trends of methotrexate for psoriasis in Argentina: results of a national survey. J Dermatolog Treat. 2017;28:631-634.
|
2017 |
221 |
CS |
Argentina |
Public |
Adherence to treatment guidelines |
Lopes N, et al.1616 Lopes N, Suzuki C, Machado P. Health Care Resource Utilization Among Patients with Moderate-To-Severe Plaque Psoriasis In Brazil. Value Health. 2017;20:A567.
|
2017 |
188 |
CS |
Brazil |
Private |
Access to medication/medical care |
Cataño J, et al.2020 Cataño J, Morales M. Isoniazid toxicity and TB development during biological therapy of patients with psoriasis in Colombia. J Dermatolog Treat. 2016;27:414-7.
|
2016 |
101 |
PC |
Colombia |
Public |
Opportunistic and endemic infections |